It is possible that signaling from a fibrotic microenvironment along with the cell-intrinsic activation of these growth factor pathways accelerate the acquisition of a tumor-initiating ability among CRC cells that express GOF mutant p53 and loss of wild-type p53. The gene discussed is TP53; the disease is colorectal carcinoma.